Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Veracyte Inc (NQ: VCYT )

47.68 USD -1.20 (-2.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 394,371
Open 49.21
Bid (Size) 44.00 (1)
Ask (Size) 53.00 (1)
Prev. Close 48.88
Today's Range 47.00 - 49.21
52wk Range 30.68 - 86.03
Shares Outstanding 67,473,870
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Veracyte Announces that New NCCN Guidelines Uniquely Recommend Use of Decipher Prostate Genomic Test Score to Guide Specific Treatment for Men Following Radical Prostatectomy
New NCCN Guidelines Recommend Use of Veracyte's Decipher Prostate Genomic Test Score to Guide Specific Treatment for Men After Radical Prostatectomy 
From Business Wire News Releases
Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of Endocrinology
Veracyte has appointed Dr. Joshua Klopper as Medical Director, Endocrinology. 
From Business Wire News Releases

Performance

YTD
+0.72%
+0.72%
1 Month
-2.11%
-2.11%
3 Month
+13.71%
+13.71%
6 Month
+2.01%
+2.01%
1 Year
+50.41%
+50.41%

More News

Read More
Veracyte to Participate in Morgan Stanley 19th Annual Global Healthcare Conference
From Business Wire News Releases
Notable Two Hundred Day Moving Average Cross - VCYT
Tags Stocks
From Market News Video
Veracyte Named a San Francisco Bay Area “Top Workplace” for Eighth Consecutive Year
From Business Wire News Releases
4 Biotech Stocks For Your August 2021 Watchlist
Tags Market News
From StockMarket.com
Veracyte Completes Acquisition of HalioDx
From Business Wire News Releases
Biotech Playbook Revisited As Technicals Weaken
Tags Stocks / Equities Market News ETFs
From TalkMarkets
Veracyte Shows Rising Price Performance With Jump To 82 RS Rating
From Investor's Business Daily
Stocks To Watch: Veracyte Sees Relative Strength Rating Rise To 84
From Investor's Business Daily
Where Veracyte Stands With Analysts
Tags VCYT Analyst Ratings Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.